OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective
Soumik Das, Gnanasambandan Ramanathan
Life Sciences (2023) Vol. 316, pp. 121414-121414
Closed Access | Times Cited: 14

Showing 14 citing articles:

Influence of gut bacteria on type 2 diabetes: Mechanisms and therapeutic strategy
Xue Wen, Luming Qi, Kui Zhao
World Journal of Diabetes (2024) Vol. 16, Iss. 1
Closed Access | Times Cited: 5

Integrative Roles of Functional Foods, Microbiotics, Nutrigenetics, and Nutrigenomics in Managing Type 2 Diabetes and Obesity
H.‐C. Lam, Shih‐Ping Lin, Duc-Huy T. Nguyen, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 608-608
Open Access

Urobiome of patients with diabetic kidney disease in different stages is revealed by 2bRAD-M
Nan Li, Ying Wang, Haojun Zhang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Organic arabic coffee husk: Antioxidant and cytoprotective properties and potential impacts on selected human intestinal bacterial populations of individuals with diabetes
Thaianaly Leite Abreu, Gezaíldo Santos Silva, Antonia Dayane Jenyffer de Farias Marques, et al.
Food Research International (2024) Vol. 192, pp. 114730-114730
Closed Access | Times Cited: 2

Huperzine A as a Potential Therapeutic Drug for Diabetic Nephropathy: Insights from Transcriptome, Metabolome, Microbiome, and Network Pharmacology Analysis
Xiangjun Chen, Ying Zhang, Zhongkai Cao, et al.
Pharmacological Research (2024) Vol. 208, pp. 107392-107392
Open Access | Times Cited: 1

Diabetic Kidney Disease: Contribution of Phenyl Sulfate Derived from Dietary Tyrosine upon Gut Microbiota Catabolism
Haoxin Liu, Tram N. Diep, Ying Wang, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1153-1153
Open Access | Times Cited: 1

Management of inflammaging in kidney diseases: focusing on the current investigational drugs
Vishwadeep Shelke, Neha Dagar, Maciej Lech, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1153-1166
Closed Access

Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3–C5D chronic kidney disease
Ф. У. Дзгоева, О. В. Ремизов, V. G. Goloeva, et al.
Terapevticheskii arkhiv (2023) Vol. 95, Iss. 6, pp. 468-474
Open Access | Times Cited: 1

Page 1

Scroll to top